#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0003] In a clinical environment bacterial contaminations are a latent an unavoidable danger, particular in the surgical area, e.g. during operative interventions at a patient.
1-1	0-1	[	_	_	
1-2	1-5	0003	_	_	
1-3	5-6	]	_	_	
1-4	7-9	In	_	_	
1-5	10-11	a	_	_	
1-6	12-20	clinical	_	_	
1-7	21-32	environment	_	_	
1-8	33-42	bacterial	_	_	
1-9	43-57	contaminations	_	_	
1-10	58-61	are	_	_	
1-11	62-63	a	_	_	
1-12	64-70	latent	_	_	
1-13	71-73	an	_	_	
1-14	74-85	unavoidable	_	_	
1-15	86-92	danger	_	_	
1-16	92-93	,	_	_	
1-17	94-104	particular	_	_	
1-18	105-107	in	_	_	
1-19	108-111	the	_	_	
1-20	112-120	surgical	_	_	
1-21	121-125	area	_	_	
1-22	125-126	,	_	_	
1-23	127-130	e.g	_	_	
1-24	130-131	.	_	_	
1-25	132-138	during	_	_	
1-26	139-148	operative	_	_	
1-27	149-162	interventions	_	_	
1-28	163-165	at	_	_	
1-29	166-167	a	_	_	
1-30	168-175	patient	_	_	
1-31	175-176	.	_	_	

#Text=Primarily due to the introduction of foreign objects (implants such as catheters, osteosynthesis plates, endoprostheses, etc.) a process occurs immediately following implantation which is called in the literature a "race for the surface" [11].
2-1	177-186	Primarily	_	_	
2-2	187-190	due	_	_	
2-3	191-193	to	_	_	
2-4	194-197	the	_	_	
2-5	198-210	introduction	_	_	
2-6	211-213	of	_	_	
2-7	214-221	foreign	_	_	
2-8	222-229	objects	_	_	
2-9	230-231	(	_	_	
2-10	231-239	implants	_	_	
2-11	240-244	such	_	_	
2-12	245-247	as	_	_	
2-13	248-257	catheters	_	_	
2-14	257-258	,	_	_	
2-15	259-273	osteosynthesis	_	_	
2-16	274-280	plates	_	_	
2-17	280-281	,	_	_	
2-18	282-296	endoprostheses	_	_	
2-19	296-297	,	_	_	
2-20	298-301	etc	_	_	
2-21	301-302	.	_	_	
2-22	302-303	)	_	_	
2-23	304-305	a	_	_	
2-24	306-313	process	_	_	
2-25	314-320	occurs	_	_	
2-26	321-332	immediately	_	_	
2-27	333-342	following	_	_	
2-28	343-355	implantation	_	_	
2-29	356-361	which	_	_	
2-30	362-364	is	_	_	
2-31	365-371	called	_	_	
2-32	372-374	in	_	_	
2-33	375-378	the	_	_	
2-34	379-389	literature	_	_	
2-35	390-391	a	_	_	
2-36	392-393	"	_	_	
2-37	393-397	race	_	_	
2-38	398-401	for	_	_	
2-39	402-405	the	_	_	
2-40	406-413	surface	_	_	
2-41	413-414	"	_	_	
2-42	415-416	[	_	_	
2-43	416-418	11	_	_	
2-44	418-419	]	_	_	
2-45	419-420	.	_	_	

#Text=This refers to a competition between the body's own cells and the microorganisms introduced during the operation to populate the initially sterile surfaces of the implant.
3-1	421-425	This	_	_	
3-2	426-432	refers	_	_	
3-3	433-435	to	_	_	
3-4	436-437	a	_	_	
3-5	438-449	competition	_	_	
3-6	450-457	between	_	_	
3-7	458-461	the	_	_	
3-8	462-468	body's	_	_	
3-9	469-472	own	_	_	
3-10	473-478	cells	_	_	
3-11	479-482	and	_	_	
3-12	483-486	the	_	_	
3-13	487-501	microorganisms	_	_	
3-14	502-512	introduced	_	_	
3-15	513-519	during	_	_	
3-16	520-523	the	_	_	
3-17	524-533	operation	_	_	
3-18	534-536	to	_	_	
3-19	537-545	populate	_	_	
3-20	546-549	the	_	_	
3-21	550-559	initially	_	_	
3-22	560-567	sterile	_	_	
3-23	568-576	surfaces	_	_	
3-24	577-579	of	_	_	
3-25	580-583	the	_	_	
3-26	584-591	implant	_	_	
3-27	591-592	.	_	_	

#Text=If the implant surface is initially colonized excessively by bacterial cells and a manifest infection occurs the immune mechanisms of the human body are induced, and the possibility arises that the implant is rejected.
4-1	593-595	If	_	_	
4-2	596-599	the	_	_	
4-3	600-607	implant	_	_	
4-4	608-615	surface	_	_	
4-5	616-618	is	_	_	
4-6	619-628	initially	_	_	
4-7	629-638	colonized	_	_	
4-8	639-650	excessively	_	_	
4-9	651-653	by	_	_	
4-10	654-663	bacterial	_	_	
4-11	664-669	cells	_	_	
4-12	670-673	and	_	_	
4-13	674-675	a	_	_	
4-14	676-684	manifest	_	_	
4-15	685-694	infection	_	_	
4-16	695-701	occurs	_	_	
4-17	702-705	the	_	_	
4-18	706-712	immune	_	_	
4-19	713-723	mechanisms	_	_	
4-20	724-726	of	_	_	
4-21	727-730	the	_	_	
4-22	731-736	human	_	_	
4-23	737-741	body	_	_	
4-24	742-745	are	_	_	
4-25	746-753	induced	_	_	
4-26	753-754	,	_	_	
4-27	755-758	and	_	_	
4-28	759-762	the	_	_	
4-29	763-774	possibility	_	_	
4-30	775-781	arises	_	_	
4-31	782-786	that	_	_	
4-32	787-790	the	_	_	
4-33	791-798	implant	_	_	
4-34	799-801	is	_	_	
4-35	802-810	rejected	_	_	
4-36	810-811	.	_	_	

#Text=In most cases, implants colonized by bacteria must be removed to treat the infection since even high concentrations of effective antibiotics cannot achieved a complete eradication of adhering bacteria [12, 13].
5-1	812-814	In	_	_	
5-2	815-819	most	_	_	
5-3	820-825	cases	_	_	
5-4	825-826	,	_	_	
5-5	827-835	implants	_	_	
5-6	836-845	colonized	_	_	
5-7	846-848	by	_	_	
5-8	849-857	bacteria	_	_	
5-9	858-862	must	_	_	
5-10	863-865	be	_	_	
5-11	866-873	removed	_	_	
5-12	874-876	to	_	_	
5-13	877-882	treat	_	_	
5-14	883-886	the	_	_	
5-15	887-896	infection	_	_	
5-16	897-902	since	_	_	
5-17	903-907	even	_	_	
5-18	908-912	high	_	_	
5-19	913-927	concentrations	_	_	
5-20	928-930	of	_	_	
5-21	931-940	effective	_	_	
5-22	941-952	antibiotics	_	_	
5-23	953-959	cannot	_	_	
5-24	960-968	achieved	_	_	
5-25	969-970	a	_	_	
5-26	971-979	complete	_	_	
5-27	980-991	eradication	_	_	
5-28	992-994	of	_	_	
5-29	995-1003	adhering	_	_	
5-30	1004-1012	bacteria	_	_	
5-31	1013-1014	[	_	_	
5-32	1014-1016	12	_	_	
5-33	1016-1017	,	_	_	
5-34	1018-1020	13	_	_	
5-35	1020-1021	]	_	_	
5-36	1021-1022	.	_	_	

#Text=If the implant surfaces are devised in a highly toxic manner, however, colonization by the body's own cells required for integration of the implant is inhibited at the same time.
6-1	1023-1025	If	_	_	
6-2	1026-1029	the	_	_	
6-3	1030-1037	implant	_	_	
6-4	1038-1046	surfaces	_	_	
6-5	1047-1050	are	_	_	
6-6	1051-1058	devised	_	_	
6-7	1059-1061	in	_	_	
6-8	1062-1063	a	_	_	
6-9	1064-1070	highly	_	_	
6-10	1071-1076	toxic	_	_	
6-11	1077-1083	manner	_	_	
6-12	1083-1084	,	_	_	
6-13	1085-1092	however	_	_	
6-14	1092-1093	,	_	_	
6-15	1094-1106	colonization	_	_	
6-16	1107-1109	by	_	_	
6-17	1110-1113	the	_	_	
6-18	1114-1120	body's	_	_	
6-19	1121-1124	own	_	_	
6-20	1125-1130	cells	_	_	
6-21	1131-1139	required	_	_	
6-22	1140-1143	for	_	_	
6-23	1144-1155	integration	_	_	
6-24	1156-1158	of	_	_	
6-25	1159-1162	the	_	_	
6-26	1163-1170	implant	_	_	
6-27	1171-1173	is	_	_	
6-28	1174-1183	inhibited	_	_	
6-29	1184-1186	at	_	_	
6-30	1187-1190	the	_	_	
6-31	1191-1195	same	_	_	
6-32	1196-1200	time	_	_	
6-33	1200-1201	.	_	_	

#Text=This effect is especially undesirable for long-term implants, such as hip joint endoprostheses.
7-1	1202-1206	This	_	_	
7-2	1207-1213	effect	_	_	
7-3	1214-1216	is	_	_	
7-4	1217-1227	especially	_	_	
7-5	1228-1239	undesirable	_	_	
7-6	1240-1243	for	_	_	
7-7	1244-1253	long-term	_	_	
7-8	1254-1262	implants	_	_	
7-9	1262-1263	,	_	_	
7-10	1264-1268	such	_	_	
7-11	1269-1271	as	_	_	
7-12	1272-1275	hip	_	_	
7-13	1276-1281	joint	_	_	
7-14	1282-1296	endoprostheses	_	_	
7-15	1296-1297	.	_	_	

#Text=A colonization with vital body cells promotes the integration of the implant and impedes an infection.
#Text=[0004] Therefore it is an object of the present invention to provide a coating for implants which inhibits the growth of introduced microorganisms on these implants, particularly the growth of bacteria, and which subsequently provides a biocompatible surface for the body's own cells.
#Text=[0005] According to the present invention, this has been achieved by a method according to claim 1 and an implant which can be prepared according to this method.
8-1	1298-1299	A	_	_	
8-2	1300-1312	colonization	_	_	
8-3	1313-1317	with	_	_	
8-4	1318-1323	vital	_	_	
8-5	1324-1328	body	_	_	
8-6	1329-1334	cells	_	_	
8-7	1335-1343	promotes	_	_	
8-8	1344-1347	the	_	_	
8-9	1348-1359	integration	_	_	
8-10	1360-1362	of	_	_	
8-11	1363-1366	the	_	_	
8-12	1367-1374	implant	_	_	
8-13	1375-1378	and	_	_	
8-14	1379-1386	impedes	_	_	
8-15	1387-1389	an	_	_	
8-16	1390-1399	infection	_	_	
8-17	1399-1400	.	_	_	
8-18	1401-1402	[	*[1]	8-95[2_1]	
8-19	1402-1406	0004	*[1]	_	
8-20	1406-1407	]	*[1]	_	
8-21	1408-1417	Therefore	*[1]	_	
8-22	1418-1420	it	*[1]	_	
8-23	1421-1423	is	*[1]	_	
8-24	1424-1426	an	*[1]	_	
8-25	1427-1433	object	*[1]	_	
8-26	1434-1436	of	*[1]	_	
8-27	1437-1440	the	*[1]	_	
8-28	1441-1448	present	*[1]	_	
8-29	1449-1458	invention	*[1]	_	
8-30	1459-1461	to	*[1]	_	
8-31	1462-1469	provide	*[1]	_	
8-32	1470-1471	a	*[1]	_	
8-33	1472-1479	coating	*[1]	_	
8-34	1480-1483	for	*[1]	_	
8-35	1484-1492	implants	*[1]	_	
8-36	1493-1498	which	*[1]	_	
8-37	1499-1507	inhibits	*[1]	_	
8-38	1508-1511	the	*[1]	_	
8-39	1512-1518	growth	*[1]	_	
8-40	1519-1521	of	*[1]	_	
8-41	1522-1532	introduced	*[1]	_	
8-42	1533-1547	microorganisms	*[1]	_	
8-43	1548-1550	on	*[1]	_	
8-44	1551-1556	these	*[1]	_	
8-45	1557-1565	implants	*[1]	_	
8-46	1565-1566	,	*[1]	_	
8-47	1567-1579	particularly	*[1]	_	
8-48	1580-1583	the	*[1]	_	
8-49	1584-1590	growth	*[1]	_	
8-50	1591-1593	of	*[1]	_	
8-51	1594-1602	bacteria	*[1]	_	
8-52	1602-1603	,	*[1]	_	
8-53	1604-1607	and	*[1]	_	
8-54	1608-1613	which	*[1]	_	
8-55	1614-1626	subsequently	*[1]	_	
8-56	1627-1635	provides	*[1]	_	
8-57	1636-1637	a	*[1]	_	
8-58	1638-1651	biocompatible	*[1]	_	
8-59	1652-1659	surface	*[1]	_	
8-60	1660-1663	for	*[1]	_	
8-61	1664-1667	the	*[1]	_	
8-62	1668-1674	body's	*[1]	_	
8-63	1675-1678	own	*[1]	_	
8-64	1679-1684	cells	*[1]	_	
8-65	1684-1685	.	*[1]	_	
8-66	1686-1687	[	_	_	
8-67	1687-1691	0005	_	_	
8-68	1691-1692	]	_	_	
8-69	1693-1702	According	_	_	
8-70	1703-1705	to	_	_	
8-71	1706-1709	the	_	_	
8-72	1710-1717	present	_	_	
8-73	1718-1727	invention	_	_	
8-74	1727-1728	,	_	_	
8-75	1729-1733	this	_	_	
8-76	1734-1737	has	_	_	
8-77	1738-1742	been	_	_	
8-78	1743-1751	achieved	_	_	
8-79	1752-1754	by	_	_	
8-80	1755-1756	a	_	_	
8-81	1757-1763	method	_	_	
8-82	1764-1773	according	_	_	
8-83	1774-1776	to	_	_	
8-84	1777-1782	claim	_	_	
8-85	1783-1784	1	_	_	
8-86	1785-1788	and	_	_	
8-87	1789-1791	an	_	_	
8-88	1792-1799	implant	_	_	
8-89	1800-1805	which	_	_	
8-90	1806-1809	can	_	_	
8-91	1810-1812	be	_	_	
8-92	1813-1821	prepared	_	_	
8-93	1822-1831	according	_	_	
8-94	1832-1834	to	_	_	
8-95	1835-1839	this	*[2]	_	
8-96	1840-1846	method	*[2]	_	
8-97	1846-1847	.	_	_	

#Text=According to the invention, also the use of the implant for an implantation into patients is comprised.
9-1	1848-1857	According	_	_	
9-2	1858-1860	to	_	_	
9-3	1861-1864	the	_	_	
9-4	1865-1874	invention	_	_	
9-5	1874-1875	,	_	_	
9-6	1876-1880	also	_	_	
9-7	1881-1884	the	_	_	
9-8	1885-1888	use	_	_	
9-9	1889-1891	of	_	_	
9-10	1892-1895	the	_	_	
9-11	1896-1903	implant	_	_	
9-12	1904-1907	for	_	_	
9-13	1908-1910	an	_	_	
9-14	1911-1923	implantation	_	_	
9-15	1924-1928	into	_	_	
9-16	1929-1937	patients	_	_	
9-17	1938-1940	is	_	_	
9-18	1941-1950	comprised	_	_	
9-19	1950-1951	.	_	_	

#Text=Other embodiments of the present invention become clear from the dependent claims and the following specification.
10-1	1952-1957	Other	_	_	
10-2	1958-1969	embodiments	_	_	
10-3	1970-1972	of	_	_	
10-4	1973-1976	the	_	_	
10-5	1977-1984	present	_	_	
10-6	1985-1994	invention	_	_	
10-7	1995-2001	become	_	_	
10-8	2002-2007	clear	_	_	
10-9	2008-2012	from	_	_	
10-10	2013-2016	the	_	_	
10-11	2017-2026	dependent	_	_	
10-12	2027-2033	claims	_	_	
10-13	2034-2037	and	_	_	
10-14	2038-2041	the	_	_	
10-15	2042-2051	following	_	_	
10-16	2052-2065	specification	_	_	
10-17	2065-2066	.	_	_	

#Text=Specification
#Text=[0006] According to the invention there is provided a method for the preparation of a biocompatible titanium oxide coating containing metal ions on an implant by which an implant can be prepared wherein the metal ions are released from the coating into the surroundings under physiological conditions and wherein the metal ions are homogenously dispersed throughout the coating.
11-1	2067-2080	Specification	_	_	
11-2	2081-2082	[	_	_	
11-3	2082-2086	0006	_	_	
11-4	2086-2087	]	_	_	
11-5	2088-2097	According	_	_	
11-6	2098-2100	to	_	_	
11-7	2101-2104	the	_	_	
11-8	2105-2114	invention	_	_	
11-9	2115-2120	there	_	_	
11-10	2121-2123	is	_	_	
11-11	2124-2132	provided	_	_	
11-12	2133-2134	a	_	_	
11-13	2135-2141	method	_	_	
11-14	2142-2145	for	_	_	
11-15	2146-2149	the	_	_	
11-16	2150-2161	preparation	_	_	
11-17	2162-2164	of	_	_	
11-18	2165-2166	a	_	_	
11-19	2167-2180	biocompatible	_	_	
11-20	2181-2189	titanium	_	_	
11-21	2190-2195	oxide	_	_	
11-22	2196-2203	coating	_	_	
11-23	2204-2214	containing	_	_	
11-24	2215-2220	metal	_	_	
11-25	2221-2225	ions	_	_	
11-26	2226-2228	on	_	_	
11-27	2229-2231	an	_	_	
11-28	2232-2239	implant	_	_	
11-29	2240-2242	by	_	_	
11-30	2243-2248	which	_	_	
11-31	2249-2251	an	_	_	
11-32	2252-2259	implant	_	_	
11-33	2260-2263	can	_	_	
11-34	2264-2266	be	_	_	
11-35	2267-2275	prepared	_	_	
11-36	2276-2283	wherein	_	_	
11-37	2284-2287	the	_	_	
11-38	2288-2293	metal	_	_	
11-39	2294-2298	ions	_	_	
11-40	2299-2302	are	_	_	
11-41	2303-2311	released	_	_	
11-42	2312-2316	from	_	_	
11-43	2317-2320	the	_	_	
11-44	2321-2328	coating	_	_	
11-45	2329-2333	into	_	_	
11-46	2334-2337	the	_	_	
11-47	2338-2350	surroundings	_	_	
11-48	2351-2356	under	_	_	
11-49	2357-2370	physiological	_	_	
11-50	2371-2381	conditions	_	_	
11-51	2382-2385	and	_	_	
11-52	2386-2393	wherein	_	_	
11-53	2394-2397	the	_	_	
11-54	2398-2403	metal	_	_	
11-55	2404-2408	ions	_	_	
11-56	2409-2412	are	_	_	
11-57	2413-2425	homogenously	_	_	
11-58	2426-2435	dispersed	_	_	
11-59	2436-2446	throughout	_	_	
11-60	2447-2450	the	_	_	
11-61	2451-2458	coating	_	_	
11-62	2458-2459	.	_	_	
